Methamphetamine is not an opioid. It is a stimulant, which means it belongs to an entirely different drug class, works on different brain chemicals, produces different effects on the body, and requires different emergency responses in an overdose. The confusion is understandable given how often these substances appear together in news coverage of the drug crisis, but pharmacologically they are opposites.
How Stimulants and Opioids Differ
Drugs are classified by what they do to the central nervous system. Stimulants speed up the messages traveling between the brain and the body: they raise heart rate, increase blood pressure, boost alertness, and suppress appetite. Methamphetamine is one of the most potent stimulants that exists. Other drugs in this category include cocaine, amphetamine (Adderall), and MDMA.
Opioids do roughly the opposite. They are depressants that slow brain activity, relieve pain, reduce coordination, and suppress breathing. Common opioids include heroin, fentanyl, oxycodone, and morphine. Rather than speeding the body up, opioids sedate it.
At the brain level, the two classes act on completely different targets. Opioids bind to mu-opioid receptors, which are involved in pain relief and sedation. Methamphetamine floods the brain with dopamine by forcing nerve cells to release it and blocking its reuptake. Both drugs activate the brain’s reward system through dopamine, which is why both are highly addictive, but they get there by entirely different routes.
Why the Distinction Matters in an Overdose
Recognizing whether someone is overdosing on a stimulant or an opioid can be lifesaving, because the emergencies look different and the available treatments don’t cross over.
An opioid overdose typically causes unresponsiveness, extremely slow or stopped breathing (sometimes just one breath every three to five seconds), blue or gray skin, and cold, clammy skin. Naloxone (Narcan) reverses an opioid overdose by knocking opioids off their receptors. It has no beneficial effect on a methamphetamine overdose. In fact, animal research has shown that naloxone can actually intensify certain stimulant effects by removing the natural braking system that the brain’s own opioid chemicals provide.
A methamphetamine overdose, sometimes called “overamping,” looks very different. Warning signs include dangerously high body temperature, seizures, stroke symptoms (sudden numbness, severe headache, blurred vision, loss of coordination), and signs of a heart attack such as chest pressure or pain radiating to the arms, jaw, or back. There is no reversal drug for a stimulant overdose. Treatment is supportive: cooling the body, controlling seizures, and stabilizing heart rhythm in a hospital setting.
No FDA-Approved Medication for Meth Addiction
One of the starkest practical differences between these two drug classes is what’s available for people trying to quit. Opioid use disorder has several well-established medications: methadone, buprenorphine, and naltrexone all have FDA approval and strong evidence behind them. Methamphetamine use disorder has no FDA-approved medication at all. Despite numerous clinical trials, nothing has cleared the bar yet. The most promising lead so far is a combination of bupropion (an antidepressant also used for smoking cessation) and injectable naltrexone, which showed effectiveness in a Phase III clinical trial. But for now, behavioral therapies remain the primary treatment approach.
Interestingly, methamphetamine itself does have one narrow medical use. A pharmaceutical version called Desoxyn is FDA-approved for treating ADHD in children aged six and older, prescribed at carefully controlled doses of 20 to 25 milligrams per day. This is a tiny fraction of what people use recreationally, and the context is entirely different from illicit use.
Why People Confuse Them
Part of the confusion comes from the fact that methamphetamine and opioids frequently appear in the same headlines, the same communities, and sometimes the same drug supply. Some people use both simultaneously, a practice called “speedballing” when it involves a stimulant and a depressant together. The combination is especially dangerous because the stimulant can mask signs of opioid sedation, making it harder to recognize when someone is approaching a fatal opioid overdose.
There’s also a contamination risk. A 2023-2024 study that tested illicit methamphetamine samples in Los Angeles found that 88% contained only methamphetamine, but the remaining 12% were mixed with other substances. Fentanyl, a synthetic opioid, was detected in 3 out of 201 samples. That’s a small percentage, but fentanyl is active at microgram doses, meaning even trace contamination can cause an opioid overdose in someone who thought they were only using a stimulant. This is one reason public health agencies recommend that people who use any illicit drugs keep naloxone on hand, even if opioids aren’t what they intend to use.
Quick Comparison
- Drug class: Methamphetamine is a stimulant. Opioids (heroin, fentanyl, oxycodone) are depressants.
- Effect on the body: Meth speeds up heart rate, raises blood pressure, and increases alertness. Opioids slow breathing, reduce pain, and cause sedation.
- Brain mechanism: Meth floods the brain with dopamine directly. Opioids bind to mu-opioid receptors.
- Overdose signs: Meth causes high body temperature, seizures, stroke, and heart attack. Opioids cause slowed breathing, unresponsiveness, and blue skin.
- Overdose reversal: Naloxone (Narcan) reverses opioid overdoses. No reversal agent exists for methamphetamine.
- Addiction medications: Opioid use disorder has three FDA-approved medications. Methamphetamine use disorder has none.